Your cart is empty
Add prompt packs to continue
This definitive collection of prompts for neurologists has been designed to transform modern clinical practice through the integration of advanced artificial intelligence. Optimize diagnostic accuracy, customize complex treatment plans, and streamline paraclinical study analysis with specialty-optimized tools. Each prompt allows us to address neurological cases with a precision medicine approach, reducing the administrative burden and promoting decision making based on updated evidence. By implementing these structures, the specialist will be able to delve into the analysis of neurodegenerative, vascular and immunological pathologies with unprecedented clarity. This library not only improves consultation efficiency, but also raises the quality of patient care through synthesis of scientific literature and ultra-specific monitoring protocols. It is the indispensable resource for the neurologist who seeks to lead the technological vanguard in the field of neurosciences.
100 resources included
He acts as a neurologist expert in pain medicine and highly complex headaches. Your goal is to design a comprehensive and personalized management plan for a patient presenting with craniofacial neuropathic pain. The analysis begins by evaluating the detailed clinical profile of the patient of [Patient's age] years, who presents a picture of [Type of headache/pain] with a chronic evolution and an intensity reported on the Visual Analog Scale (VAS) of [VAS Intensity]. It is imperative that the analysis considers not only the phenomenology of pain, but also the impact on daily functionality and health-related quality of life. It deeply analyzes the associated [Comorbidities], such as mood disorders, sleep insomnia or metabolic pathologies, which could be sensitizing the central and peripheral nervous system. Critically reviews the [Previous Treatments] tested, detailing the maximum doses achieved, the duration of treatment and the specific reasons for discontinuation, either due to lack of efficacy or due to the appearance of intolerable adverse effects. Integrate [Imaging Results/Electrophysiology] findings into your clinical reasoning to confirm structural integrity or identify potential neurovascular compressions, demyelination, or space-occupying lesions. Develops a precision pharmacological strategy based on current scientific evidence (IASP and AHS guidelines). Propose a treatment scheme that includes first-line drugs such as neuromodulators (gabapentinoids) or antidepressants with antinociceptive action (tricyclic or dual), specifying a slow titration regimen to maximize adherence. If the case suggests it, discuss the relevance of second-line or adjuvant therapies, and evaluate the indication of minimally invasive procedures, such as peripheral nerve blocks, trigger point infiltration or the use of botulinum toxin type A under specific protocols for craniofacial pain. Establishes a multidisciplinary follow-up plan that includes orofacial physical rehabilitation and psychological support through cognitive-behavioral therapy for the management of chronic pain. Define clear success metrics beyond numerical VAS reduction, such as improvement in sleep pattern and return to work or social activities. Finally, it explicitly details the specific red flags or alarm signs for this patient profile that would require urgent referral to neurosurgery or diagnostic reevaluation using advanced neuroimaging tests.
He acts as a highly specialized Neurologist with a subspecialty in Sleep Medicine and extensive experience in disorders of the sleep-wake cycle. Your objective is to develop a comprehensive, personalized clinical management plan based on the most recent evidence (AASM and international guidelines) for a patient with a confirmed diagnosis of Idiopathic Hypersomnia (IH). First, it performs an in-depth analysis of the patient's clinical phenotype using the data provided: [Age and sex], [Epworth Sleepiness Scale score], [Mean sleep latency on the Multiple Latency Sleep Test - TLMS], [Presence of SOREMPs], and [Total sleep duration in 24 hours by actigraphy or extended PSG]. It is essential that you determine whether the patient has the 'prolonged sleep' phenotype (more than 10-11 hours) and the severity of sleep inertia (sleep drunkenness), as this will dictate the aggressiveness of the treatment. Second, it establishes a robust differential diagnosis. Explains the subtle diagnostic differences with Narcolepsy Type 2, lifestyle-induced Poor Sleep Syndrome, and hypersomnias secondary to neuropsychiatric disorders such as [Concomitant disorders: Depression, Anxiety, ADHD]. Evaluate whether there are contributing factors such as medication use [Patient's Current Drug List] that may exacerbate excessive daytime sleepiness. Third, design a stepwise pharmacological therapeutic strategy. Propose the use of first-line wakefulness-promoting agents such as Modafinil or Armodafinil, and discuss the relevance of new generation or specific indication drugs such as Calcium, Magnesium, Potassium and Sodium Oxybate (Xywav) for the control of nocturnal and morning sleep inertia. It includes titration protocols, management of [Expected side effects: headache, nausea, palpitations] and therapeutic switch criteria in case of lack of efficacy. Finally, it integrates a non-pharmacological and safety management plan. Provides recommendations on sleep hygiene adapted to HI (where naps are often not restorative), safety guidelines for driving vehicles and machinery, and work or academic accommodation strategies for [Patient Name or Profile]. It concludes with a long-term follow-up system using the Idiopathic Hypersomnia Severity Scale (IHSS) to measure quality of life and functional impact.
He acts as a Senior Interventional Neurologist and Director of the Stroke Unit in a high complexity hospital. Your objective is to write a comprehensive and ultra-detailed clinical protocol for the implementation and execution of [Mechanical Thrombectomy] in patients with acute ischemic stroke, integrating the most recent AHA/ASA and ESO guidelines. The document must serve as an operational reference for the multidisciplinary team (neurology, radiology, anesthesia and nursing) in a [Name of Center or Unit] environment. The protocol should begin with the triage phase and strict eligibility criteria. Defines the parameters for the standard window (0-6 hours) and the extended window (6-24 hours) using the criteria from the DAWN and DEFUSE-3 studies. It is imperative to detail the advanced neuroimaging requirements, including the use of [Neuroimaging Software: RAPID/Olea/Viz.ai], the acceptable ischemic core volume in [Imaging Technique: Perfusion CT/MRI], and the minimum ASPECT score required to proceed with the intervention. In the technical procedure section, it describes in detail the vascular approach strategy, from femoral or radial puncture to the preferred recanalization technique (ADAPT pure aspiration technique, Solumbra combined technique or use of Stent-Retriever as first line). Includes specifications on intra-procedural blood pressure management, maintaining a SBP between [Desired SBP Range], and making decisions on the type of anesthesia (conscious sedation vs. general anesthesia) based on the patient's clinical stability and injury profile. Finally, it develops an exhaustive section on post-thrombectomy care and management of complications. It establishes the surveillance protocol in the Stroke Unit during the first 24 hours, the frequency of the NIHSS control scales, the reperfusion objectives according to the TICI scale (aiming for a TICI 2b/3) and the management of hemorrhagic transformation if it occurs. Includes a table of target times (KPIs) to reduce 'Door-to-Groin' and 'Door-to-Reperfusion' times, adapted to the infrastructure of [Hospital Location].